Maravai Lifesciences Financials

Maravai Lifesciences Stock Summary

Maravai Lifesciences competes with Roivant Sciences, Krystal Biotech, Akero Therapeutics, Apellis Pharmaceuticals, and Halozyme Therapeutics. Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California. Maravai LifeSciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 470 people.

Maravai Lifesciences Key Financial Ratios

Maravai Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Maravai Lifesciences's current stock value. Our valuation model uses many indicators to compare Maravai Lifesciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Maravai Lifesciences competition to find correlations between indicators driving Maravai Lifesciences's intrinsic value. More Info.Maravai Lifesciences Holdings is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Maravai Lifesciences' earnings, one of the primary drivers of an investment's value.

Maravai Lifesciences Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Maravai Lifesciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Maravai Lifesciences Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Maravai Lifesciences Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Maravai Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Maravai Lifesciences's daily price indicators and compare them against related drivers.

When running Maravai Lifesciences' price analysis, check to measure Maravai Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maravai Lifesciences is operating at the current time. Most of Maravai Lifesciences' value examination focuses on studying past and present price action to predict the probability of Maravai Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maravai Lifesciences' price. Additionally, you may evaluate how the addition of Maravai Lifesciences to your portfolios can decrease your overall portfolio volatility.